Leveraging our 3D cell culture technology as well as our expertise in liver biology and ADME/Tox, Corning has developed an all-in-one solution for the development of 3D liver models that better recapitulate in vivo behavior. The Corning HepGo assay-ready 3D liver spheroid kit delivers a more physiologically relevant model over traditional 2D models for reliable, accurate drug safety screening and drug efficacy testing.
The HepGo assay-ready 3D liver spheroid kit is a plug-and-play solution that includes 96 pre-plated primary human hepatocyte (PHH) spheroids in a 96-well spheroid microplate (one uniform spheroid per well) and companion media. The kit provides easy access to 3D PHH liver spheroids, which may improve accuracy and efficiency in various culture applications, including hepatotoxicity assays.
With its assay-ready platform, the HepGo kit allows both imaging-based and biochemical assays to be performed on the same plate—no transfer required. This streamlines the process, reduces time and cost, and reduces the potential for error, empowering you to focus on generating reliable, accurate, reproducible data.
